By Dorothy Atkins ( July 19, 2021, 10:05 PM EDT) -- During a California federal jury trial Monday over claims Novartis owes a Daiichi Sankyo subsidiary royalties for infringing its skin cancer patents, Novartis' patent damages expert criticized the unit's $47.2 million royalties estimate and testified that any royalties should be $1.89 million at most....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.